The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery.

导出 OA

翻译打印收藏纠错

第一作者： Shrirang V,Ranade

第一单位： Genentech, Inc, South San Francisco, CA, USA.

作者： Shrirang V,Ranade ^[1] ; Mark R,Wieland ^[2] ; Tammy,Tam ^[1] ; Jennifer C,Rea ^[1] ; Judit,Horvath ^[1] ; Aaron R,Hieb ^[1] ; Weitao,Jia ^[1] ; Lori,Grace ^[1] ; Giulio,Barteselli ^[1] ; Jay M,Stewart ^[3]

作者单位： Genentech, Inc, South San Francisco, CA, USA. ^[1] Northern California Retina Vitreous Associates, San Jose, CA, USA. ^[2] Department of Ophthalmology, University of California, San Francisco, CA, USA. ^[3]

关键词 Port Delivery System Ranibizumab continuous drug delivery nAMD ocular implant retina

主题词药物释放系统(Drug Delivery Systems);结果可重复性(Reproducibility of Results);视网膜(Retina)

DOI 10.1080/10717544.2022.2069301

PMID 35499315

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交